Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Refine Results

The theme for this year’s World Immunization Week, “#VaccinesWork”, rings true for the many diseases from which vaccines are protecting people of all ages across the globe.  Yet, there are more diseases, for which vaccines may work, once they make it through all the development phases into the hands of the patients who need them.  For example, drug resistance and large populations at-risk contribute to the pressing need for development of a malaria vaccine that works. Malaria – Still a deadly threat Malaria has been, and still is, among the world’s deadliest diseases. King Tut and Genghis Khan died from malaria, as may up to half of the people who have ever lived.1 There were 212 million... Read More

Topics

Vaccines

Despite significant annual variation in research funding and global funding totals that fall far short of the field’s reported needs, the global market in tuberculosis (TB) diagnostics and treatments is expected to grow at a compound annual growth rate (CAGR) of 4.2% by 2025. That’s good news as we acknowledge another World TB Day—and another year dedicated to “Uniting to End TB”. Some of this anticipated growth can be attributed to the increase in funding partnerships enabling smoother international collaboration and cohesive approaches to research. By uniting to set goals for drug and diagnostics development—and redirecting efforts when certain avenues of research  do not provide the... Read More

Topics

Vaccines

When most people think of emerging threats to public health, tuberculosis (TB) is unlikely to rise to the forefront of their minds. After all, TB has a long history and has been a well-known global public health challenge for more than a century. But it’s back on the list of emerging health threats due to its change in nature. TB is now increasingly drug resistant, and resistant strains of the disease are spreading quickly, making the infection harder to treat. That’s why multi drug-resistant (MDR-TB) and extensively drug-resistant TB (XDR-TB) can also be given the reputation of a “superbug”.  As we know, World Tuberculosis Day commemorates the day in 1882 when Dr Robert Koch astounded the... Read More

Topics

Vaccines